Takeda subsidiary ordered to pay Bayer $182m after overturn bid fails
27-08-2019
AG weighs in on Bayer patent case
11-04-2019
Bayer takes pre-emptive strike to protect haemophilia treatment
31-08-2017
Xesai / iStockphoto.com
A US jury has ordered pharmaceutical company Baxalta Inc. to pay $155 million to Bayer Healthcare following a patent infringement trial.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Bayer Healthcare, Baxalta Inc., Takeda Pharmaceutical Company, Factor VIII conjugates, haemophilia, patent infringement, patent licensing
